HLX02
HLX02-BC01
Phase 3 mab completed
Quick answer
HLX02 for Breast Cancer is a Phase 3 program (mab) at Shanghai Henlius Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Henlius Biotech
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed